[go: up one dir, main page]

AU2001268422A1 - Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders - Google Patents

Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

Info

Publication number
AU2001268422A1
AU2001268422A1 AU2001268422A AU6842201A AU2001268422A1 AU 2001268422 A1 AU2001268422 A1 AU 2001268422A1 AU 2001268422 A AU2001268422 A AU 2001268422A AU 6842201 A AU6842201 A AU 6842201A AU 2001268422 A1 AU2001268422 A1 AU 2001268422A1
Authority
AU
Australia
Prior art keywords
agmatine
seizure
epilepsy
treatment
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268422A
Inventor
Aimee K. Bence
Peter A. Crooks
David R. Worthen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of AU2001268422A1 publication Critical patent/AU2001268422A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001268422A 2000-06-15 2001-06-15 Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders Abandoned AU2001268422A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21153200P 2000-06-15 2000-06-15
US60211532 2000-06-15
PCT/US2001/019095 WO2001095897A1 (en) 2000-06-15 2001-06-15 Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

Publications (1)

Publication Number Publication Date
AU2001268422A1 true AU2001268422A1 (en) 2001-12-24

Family

ID=22787315

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268422A Abandoned AU2001268422A1 (en) 2000-06-15 2001-06-15 Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

Country Status (3)

Country Link
US (1) US7816407B2 (en)
AU (1) AU2001268422A1 (en)
WO (1) WO2001095897A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060111743A1 (en) * 2004-11-19 2006-05-25 Gurney Harry C Jr Method for arresting seizure activity
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US10435356B1 (en) * 2007-09-18 2019-10-08 Thermolife International, Llc Amino acid compositions
US10426792B1 (en) 2007-09-18 2019-10-01 Thermolife International, Llc Amino acid compositions
US10646508B1 (en) 2007-09-18 2020-05-12 Thermolife International, Llc Method of safely administering nitrate dietary supplements and compositions
US10426750B1 (en) 2007-09-18 2019-10-01 Thermolife International, Llc Amino acid supplement formulations
WO2010030470A1 (en) * 2008-09-11 2010-03-18 Gilad Gad M Agmatine containing dietary supplements, nutraceuticals, and foods
US8916612B2 (en) * 2008-09-11 2014-12-23 Gad Gilad Agmatine containing dietary supplements, nutraceuticals, and foods
AU2012242565B2 (en) 2011-04-13 2017-05-11 Thermolife International, Llc N-Acetyl Beta Alanine methods of use
KR101497932B1 (en) 2013-05-08 2015-03-03 건국대학교 산학협력단 Composition comprising Agmatine or its pharmaceutically acceptable salt for preventing or treating autism spectrum disorder
US20150182479A1 (en) * 2013-12-30 2015-07-02 Topaz Ventures, Inc. Method of delivering agmatine for medical treatment
EA031654B1 (en) 2014-01-10 2019-02-28 Глэксосмитклайн Интеллекчуал Проперти (No.2) Лимитед Hydroxy formamide derivatives and their use
RU2548758C1 (en) * 2014-06-17 2015-04-20 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения Российской Федерации Method for predicting early neonatal convulsive disorder in children suffering perinatal injuries of central nervous system
US9993447B2 (en) 2015-09-14 2018-06-12 JW Nutritional, LLC Systems and methods for increasing agmatine cellular uptake by oral administration
KR20190121569A (en) * 2018-04-18 2019-10-28 건국대학교 글로컬산학협력단 Pharmaceutical Composition for Improving Fragile X Syndrome Comprising Agmatine or its derivatives
US12036193B2 (en) * 2019-09-15 2024-07-16 Celagenex Research (India) Pvt. Ltd. Synergistic bioactive compositions for treating neurological disorders
JP2024541338A (en) 2020-11-12 2024-11-08 サーモライフ インターナショナル， エルエルシー Methods for increasing blood oxygen saturation
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
CA3206079A1 (en) 2021-02-11 2022-08-18 Ronald Kramer A method of administering nitric oxide gas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267374A (en) 1977-07-01 1981-05-12 Merrell Toraude Et Compagnie Derivatives of amines and amino acids
US4139563A (en) 1977-07-01 1979-02-13 Merrell Toraude Et Compagnie α-ACETYLENIC DERIVATIVES OF AMINES
US4134918A (en) * 1977-09-06 1979-01-16 Merrell Toraude Et Compagnie Alpha-halomethyl derivatives of amines
US4323704A (en) 1979-06-25 1982-04-06 Merrell Toraude Et Compagnie αAcetylene and α-vinyl derivatives of amino acids
US5242947A (en) * 1988-02-10 1993-09-07 New York University Use of polyamines as ionic-channel regulating agents
US5633230A (en) 1990-10-24 1997-05-27 Allelix Biopharmaceuticals, Inc. Treatment of cytomegalovirus infection
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases
FR2753098B1 (en) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE NO SYNTHASE INHIBITOR AND AT LEAST ONE TRAP FOR REACTIVE OXYGEN FORMS
EP1014959B1 (en) * 1997-08-15 2004-10-20 Carolyn Ann Fairbanks Agmatine as a treatment for neuropathic pain
US6441156B1 (en) * 1998-12-30 2002-08-27 The United States Of America As Represented By The Department Of Health And Human Services Calcium channel compositions and methods of use thereof

Also Published As

Publication number Publication date
US20020065323A1 (en) 2002-05-30
WO2001095897A1 (en) 2001-12-20
US7816407B2 (en) 2010-10-19

Similar Documents

Publication Publication Date Title
AU2001268422A1 (en) Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
AU2002361811A8 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
SI1660458T1 (en) 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
IL161267A0 (en) Combinations for the treatment of immunoinflammatory disorders
IL155433A0 (en) Treatment of t cell disorders
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
GB0108671D0 (en) Skin treatment
GB0213869D0 (en) The treatment of pain
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
WO2003050137A3 (en) Toll-like receptor 4 mutations
AU2003293500A1 (en) Lactoferrin in the reduction of pain
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
GB0105899D0 (en) Fibrosis reduction treatment
IL164901A0 (en) Optically active beta-aminoketones, optically active 1,3-aminoalcohols and processes for preparing them
IL164951A0 (en) The treatment of pain with lfendropil
AU2002328383A1 (en) Equipment for treating painful points in the organism
AU2002358267A1 (en) Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
AU2002357691A1 (en) Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
GB0211297D0 (en) Pain treatment
GB0119173D0 (en) Pain treatment
GB0115489D0 (en) Pain treatment
GB0222948D0 (en) The treatment of emesis,nausea and other disorders
GB0216223D0 (en) The treatment of emesis, nausea and other disorders